News
Market and company headlines
Palatin Technologies, Inc. (PTN) Q4 2026 Earnings Call September 28, 2026 11:00 AM EDTCompany ParticipantsCarl Spana - Co-Founder, President, CEO &...

Palatin Technologies, Inc. (Nasdaq: PTN), a biopharmaceutical company developing medicines that target the melanocortin receptor ("MCR") system, today reported financial results for the fiscal year ended June 30, 2026 and provided an update on its MC4R-focused obesity development programs and partnering activities.

Gainers Kodiak Sciences (NASDAQ:KOD) shares increased by 57.4% to $50.93 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 billion. Accuray (NASDAQ:ARAY) stock moved
U.S. stock futures fell as gold and silver prices slid, sending Gold Fields down 16% and other precious-metal stocks lower in premarket trading.
